Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 6, 2020

Primary Completion Date

March 28, 2022

Study Completion Date

March 28, 2022

Conditions
Malignant Skin TumorSoft Tissue Tumor, Malignant
Interventions
RADIATION

Diffusing Alpha-emitter Radiation Therapy

Diffusing Alpha-emitter Radiation Therapy (DaRT) is a method of delivering interstitial brachytherapy, based on the interstitial intratumoral placement of an encapsulated Radium-224 source (3.7 days half-life). These sources release short-lived alpha-emitting atoms into the tumor microenvironment by recoil. As the radioisotope has a short half-life, the majority of radiation absorption happens in the tumor.

Trial Locations (5)

10065

Memorial Sloan-Kettering Cancer Center, New York

38138

West Cancer Center & Research Institute, Germantown

50309

UnityPoint Health - John Stoddard Cancer Center, Des Moines

77089

University Cancer & Diagnostic Center, Houston

98168

Dermatology of Seattle and Bellevue, Seattle

Sponsors
All Listed Sponsors
lead

Alpha Tau Medical LTD.

INDUSTRY